510(k) Report

510(k) · Cleared

Cleared

Novatome, Model: SU101-50

K072051510(k) TraditionalCleared Oct 3, 200769-day reviewClass II21 CFR 870.4075

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Scholten Surgical Instruments, Inc. · DWZ Device, Biopsy, Endomyocardial

Cleared on Oct 3, 2007 after a 69-day review. The FDA summary names its predicate without a number.

Decided
Oct 3, 2007
Review
69 days
Class
Class II
Product code
DWZ
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K072051Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DWZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DWZ device

  1. #1 K252722 Biopsy Forcepsscore 10.7 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Scholten Bioptome
Named without a submission number
—
*—Ultra-CBX
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All DWZ devices

DWZ Device, Biopsy, Endomyocardial: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · DWZ

1in 2025

2007: 12017: 12025: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DWZ

Too few DWZ 510(k)s in any year since 2007 to give a median.

Recalls per year · DWZ

No recall names DWZ since 2007.

Adverse event reports per year · DWZ

1in 2025

2007: 22008: 12010: 32013: 12015: 12016: 12017: 42018: 72019: 52020: 52021: 52022: 142023: 102024: 42025: 1
2007high 14 (2022) · low 0 (2009)2025

MAUDE reports naming product code DWZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20080—01
20090—00
20100—03
20110—00
20120—00
20130—01
20140—00
20150—01
20160—01
20171—04
20180—07
20190—05
20200—05
20210—05
20220—014
20230—010
20240—04
20251—01
20260—0—

What is it indicated for?

The Scholten Novatome T M is a surgical device used to perform endomyocardial biopsies.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072051: Novatome, Model: SU101-50.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K072051

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026